Mir A Imran

Palo Alto, CA, United States of America

Mir A Imran

wikipedia

This inventor holds 449 USPTO granted patents and 102 published patent applications, primarily in Drug Delivery Devices (CPC class A61M31-002). Top assignees: Incube Labs, LLC, Rani Therapeutics, LLC, Cardiac Pathways Corporation. Active years: 1983-2025.

USPTO Granted Patents = 449 

% Patents Active = 68.2

Average Co-Inventor Count = 1.4

ph-index = 99

Forward Citations = 41,861(Granted Patents)

Forward Citations (Not Self Cited) = 36,746(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Pittsburgh, PA (US) (1983 - 1986)
  • Gibsonia, PA (US) (1987)
  • San Francisco, CA (US) (1988 - 1989)
  • Palo Alto, CA (US) (1988 - 1999)
  • Los Atlos Hills, CA (US) (2013)
  • Menlo Park, CA (US) (2006 - 2017)
  • San Jose, CA (US) (2023)
  • Los Altos Hills, CA (US) (1997 - 2024)
  • Los Altos, CA (US) (2012 - 2024)

Company Filing History:

goldMedal135 out of 139 
 
Incube Labs, LLC
 patents
silverMedal95 out of 97 
 
Rani Therapeutics, LLC
 patents
bronzeMedal45 out of 62 
 
Cardiac Pathways Corporation
 patents
4. 32 out of 34 
 
Intrapace, Inc.
 patents
5. 17 out of 24 
 
Spinal Modulation, Inc.
 patents
6. 16 out of 16 
 
Intelliwire, Inc.
 patents
7. 13 out of 5,509 
 
Leland Stanford Junior University
 patents
8. 11 out of 11 
 
Entrack, Inc.
 patents
9. 11 out of 11 
 
Python Medical, Inc.
 patents
10. 9 out of 16 
 
Physiometrix, Inc.
 patents
11. 8 out of 12 
 
St. Jude Medical Luxembourg Holdings Smi S.a.r.l. (“Sjm Lux Smi”)
 patents
12. 6 out of 12 
 
Intella Interventional Systems, Inc.
 patents
13. 6 out of 9 
 
Surface Genesis, Inc.
 patents
14. 5 out of 5 
 
Advanced Cytometrix, Inc.
 patents
15. 5 out of 7 
 
Datatrak, Inc.
 patents
16. 4 out of 7 
 
Cardiovasc, Inc.
 patents
17. 2 out of 5 
 
Fe3 Medical, Inc.
 patents
18. 2 out of 18 
 
Percusurge, Inc.
 patents
19. 2 out of 2 
 
Reflow, Inc.
 patents
20. 2 out of 5 
 
St. Jude Medical Luxembourg Holdings Smi S.a.r.l.
 patents
21. 2 out of 28 
 
Zonare Medical Systems, Inc.
 patents
22. 1 out of 1 
 
Advanced Cytometric Inc.
 patent
23. 1 out of 16 
 
Fox Hollow Technologies, Inc.
 patents
24. 1 out of 1 
 
Incube Laboratories LLC
 patent
25. 1 out of 110 
 
Medtronic Ave, Inc.
 patents
26. 1 out of 14 
 
Medtronic Percusurge, Inc.
 patents
27. 1 out of 1,006 
 
Medtronic Vascular, Inc.
 patents
28. 1 out of 6 
 
Mieczyslaw Mirowski
 patents
29. 1 out of 1 
 
Mircor Biomedical, Inc.
 patent
30. 1 out of 5 
 
Mirowski; Mieczyslaw
 patents
31. 1 out of 6 
 
Novasonics, Inc.
 patents
32. 1 out of 1 
 
Phyronics, Inc.
 patent
33. 1 out of 1 
 
Python, Inc.
 patent
34. 1 out of 1 
 
Spinal Modulations, Inc.
 patent
35. 1 out of 30 
 
Supra Products, Inc.
 patents
36. 1 out of 304 
 
Tc1 LLC
 patents
37. 1 out of 62 
 
Vidamed, Inc.
 patents
38. 18 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1983-2025

Loading Chart...
Areas of Expertise:
Swallowable Devices
Therapeutic Compounds
Microtablet Manufacturing
Biodegradable Implants
Neurogenic Bladder
Insulin Delivery
Pharmaceutical Compositions
Clotting Factor Preparations
Incretin Production
Urethral Catheters
Pressure Measurement
Stem Cell Treatment
449 patents (USPTO):Explore Patents

Title: Mir A Imran: Innovator in Swallowable Drug Delivery Technologies

Introduction

Mir A Imran is a prolific inventor based in Palo Alto, California, with an impressive portfolio of 428 patents. His groundbreaking work primarily focuses on innovations in drug delivery systems, aiming to enhance the effectiveness of therapeutic agents within the gastrointestinal (GI) tract.

Latest Patents

Among his latest innovations are patents for a swallowable drug delivery device and methods of drug delivery. These inventions represent advancements in medical technology, providing solutions for delivering drugs and therapeutic agents effectively within the GI tract. One of the key embodiments is a swallowable capsule designed to deliver medications into the intestinal wall or other areas of the GI lumen. This capsule incorporates a guide tube, tissue penetrating members, a delivery member, an actuating mechanism, and a release element that degrades under specific conditions in the intestine, allowing for the targeted delivery of drugs that are typically poorly absorbed or tolerated in the GI tract.

Another remarkable patent involves a device and system for the oral delivery of therapeutic compounds. This invention outlines a swallowable device, like a capsule, which contains drug preparations that are advanced into the intestinal wall and degrade to release effective doses to produce therapeutic effects. This system is particularly beneficial for drugs that are challenging to administer effectively within the digestive system.

Career Highlights

Throughout his career, Mir A Imran has made significant contributions to the field of medical technology. He has held positions in influential companies such as Incube Labs, LLC and Rani Therapeutics, LLC. His work continues to push the boundaries of how medications are delivered and absorbed in the body, showcasing his talent as an inventor.

Collaborations

Collaboration has played a vital role in Mir A Imran's journey. He has worked alongside talented individuals, including Mir Hashim and Radhika Korupolu, contributing to the development of revolutionary drug delivery systems.

Conclusion

Mir A Imran's innovative patents and contributions to drug delivery technology underscore his status as a leading inventor in the medical field. His commitment to improving the efficiency of therapeutic delivery methods continues to pave the way for advancements that could significantly enhance patient care and treatment outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…